Zobrazeno 1 - 10
of 54
pro vyhledávání: '"CHRISTOPHER V. CHIEN"'
Autor:
Julie T. Bidwell, Karen S. Lyons, James O. Mudd, Kathleen L. Grady, Jill M. Gelow, Shirin O. Hiatt, Christopher V. Chien, Christopher S. Lee
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 6 (2018)
BackgroundAlthough current guidelines emphasize the importance of social support to the success of left ventricular assist device (LVAD) therapy, few studies examine the influence of the caregiver on patient outcomes or quantify the impact of LVAD ca
Externí odkaz:
https://doaj.org/article/6c1c07df4d984e4884e1f4be170b3b3d
Autor:
Jared J. Herr, Farooq H. Sheikh, Parin J. Patel, Anuradha Lala, Christopher V. Chien, Stephanie Hsiao, Ajay Srivastava, Dawn Pedrotty, Jennifer Nowaczyk, Shannon Tompkins, Sara Ahmed, Fei Xiang, Stephen Forest, Michael Z. Tong, Forum Kamdar, Benjamin D'Souza, Ashwin Ravichandran
Publikováno v:
The American Journal of Cardiology. 185:46-52
Advanced heart failure (HF) therapies improve survival in patients with stage D HF. We sought to evaluate differences by race/ethnicity and sex in advanced HF therapy referrals and decision-making across a multicenter survey. We performed a retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a2b5e5d31dbae617a089c434411bb30
https://doi.org/10.1016/j.amjcard.2022.09.015
https://doi.org/10.1016/j.amjcard.2022.09.015
Publikováno v:
Journal of Cardiac Failure. 29:771-773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::057ea9b9e212a01676878710ed9c765b
https://doi.org/10.1016/j.cardfail.2023.01.002
https://doi.org/10.1016/j.cardfail.2023.01.002
Autor:
ADRIAN F. HERNANDEZ, NANCY M. ALBERT, LARRY A. ALLEN, REZWAN AHMED, VIKTORIA AVERINA, JOHN P. BOEHMER, MARTIN R. COWIE, CHRISTOPHER V. CHIEN, MARIE GALVAO, LIVIU KLEIN, BRIAN KWAN, CAROLYN S.P. LAM, STEPHEN B. RUBLE, CRAIG M. STOLEN, KENNETH STEIN
Publikováno v:
Journal of Cardiac Failure. 28:1245-1254
Patients with heart failure (HF) and reduced ejection fraction suffer from a relapsing and remitting disease course, where early treatment changes may improve outcomes. We assessed the clinical integration and safety of the HeartLogic multisensor ind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c07add82ae1a925af0de563122a214
https://doi.org/10.1016/j.cardfail.2022.03.349
https://doi.org/10.1016/j.cardfail.2022.03.349
Autor:
Stephanie Hsiao, Ideal-Hf investigators, Sara Ahmed, S. Forest, Christopher V. Chien, Ashwin Ravichandran, Anuradha Lala, Benjamin D’Souza, Shannon Tompkins, Ajay Srivastava, Farooq H. Sheikh, Michael Z Tong, Dawn M. Pedrotty, Fei Xiang, Jennifer Nowaczyk, Jared J Herr
Publikováno v:
Journal of Cardiac Failure. 27:1251-1259
Background Therapies for advanced heart failure (AHF) improve the likelihood of survival in a growing population of patients with stage D heart failure (HF). Successful implementation of these therapies is dependent upon timely and appropriate referr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbfe250df3fc4a7e4cb207f3e8345f72
https://doi.org/10.1016/j.cardfail.2021.05.024
https://doi.org/10.1016/j.cardfail.2021.05.024
Autor:
Benjamin D’Souza, Robert T. Cole, Navin K. Kapur, Scott C. Silvestry, Anuradha Lala, Arthur Rashad Garan, Michael Z Tong, Ajay Srivastava, Jared J Herr, Ashwin Ravichandran, Christopher V. Chien, Dale Yoo, Farooq H. Sheikh, Paolo C. Colombo, Ideal-Hf, Travis Abicht
Publikováno v:
Heart Failure Reviews
In this document, we outline the challenges faced by patients and clinicians in heart failure, specifically centered around the needed coordination of care among the various subspecialties within cardiovascular medicine. We call for a more organized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4eac59d7d0c62cb18d5c50f36121ef
https://doi.org/10.1007/s10741-020-10025-1
https://doi.org/10.1007/s10741-020-10025-1
Autor:
Prashanth Iyer, Anne M. Lachiewicz, Kara J. Levinson, Jonathan J. Juliano, Nicholas F Brazeau, Asher J Schranz, David van Duin, Ian B. Hollis, Melissa B. Miller, Melissa Jones, Luther A. Bartelt, Tessa M. Andermann, Amanda Bowen, Christopher V. Chien, Kara A. Moser
Publikováno v:
Evolution, Medicine, and Public Health
Daptomycin (DAP) is key in treating multidrug-resistant Staphylococcus infections. Diminished susceptibility to DAP is emerging among Staphylococcus epidermidis strains although mechanisms for non-susceptibility (NS) remain poorly understood. We repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b447b9593cebd82e9fb5b47a6493fd51
https://doi.org/10.1093/emph/eoaa031
https://doi.org/10.1093/emph/eoaa031
Autor:
Kenneth M Faulkner, Corrine Y Jurgens, Quin E Denfeld, Christopher V Chien, Jessica Harman Thompson, Jill M Gelow, Kathleen L Grady, Christopher S Lee
Publikováno v:
Eur J Cardiovasc Nurs
Aims Dyspnoea is a common symptom of heart failure (HF) that often prompts patients to seek treatment. Implantation of a left ventricular assist device (LVAD) has been associated with reduced dyspnoea but it is unclear if all patients experience simi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987e3c4fa334dba64c9ba2d471c96f7e
https://europepmc.org/articles/PMC9564114/
https://europepmc.org/articles/PMC9564114/
Autor:
Kevin S. Shah, John L. Jefferies, Christopher V Chien, Deidre M Mooney, Richard Cheng, Amanda R. Vest
Publikováno v:
Journal of the American College of Cardiology. 77:1375-1377
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b88abcdf20d339f9f98ae6a5c315ad0d
https://doi.org/10.1016/j.jacc.2021.01.020
https://doi.org/10.1016/j.jacc.2021.01.020
Autor:
Ian B. Hollis, Amanda C. Coniglio, Jason N. Katz, Prashanth Iyer, Christopher V. Chien, James B Henderson
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 39:1030-1035
Introduction Patients with a continuous-flow left ventricular assist device (CF-LVAD) require anticoagulation with a vitamin K antagonist to prevent thromboembolic events. Fluctuations in the international normalized ratio are associated with both in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c89abb793fdd29747270347bcc14f2
https://doi.org/10.1002/phar.2324
https://doi.org/10.1002/phar.2324